Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BCT vs Mastectomy in Early Triple-Negative Breast Cancer
NCT02464774Unknown
- Start
- Jul 2015
- Primary completion
- Dec 2022
01
Overview
Randomised, open-label trial in triple negative breast cancer (TNBC). Primary endpoint: Disease-Free Survival at 5 years. Status: unknown.
02
Conditions
triple negative breast cancer (TNBC)
Beyond the preview
Go deeper on NCT02464774.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02464774.